Use of aminoglycoside antibiotics and related compounds to study ADP-ribosylation factor (ARF)/coatomer function in Golgi traffic.
Draper
R K
RK
Department of Molecular and Cell Biology, University of Texas at Dallas, Richardson, Texas 75083-0688, USA.
Hudson
R T
RT
Hu
T
T
D020823:ADP-Ribosylation Factor 1 / Q000378:metabolism*; D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D022181:COP-Coated Vesicles / Q000737:chemistry / Q000378:metabolism*; D002240:Carbohydrate Sequence; D002460:Cell Line; D011232:Chemical Precipitation; D003510:Cyclohexanes / Q000494:pharmacology; D005455:Fluorescent Antibody Technique; D006056:Golgi Apparatus / Q000187:drug effects* / Q000378:metabolism*; D046911:Macromolecular Substances; D008744:Methylamines / Q000494:pharmacology; D008969:Molecular Sequence Data; D009355:Neomycin / Q000037:antagonists & inhibitors / Q000494:pharmacology; D011485:Protein Binding / Q000187:drug effects; D018000:Receptors, Peptide / Q000378:metabolism; D012995:Solubility / Q000187:drug effects
D000900:Anti-Bacterial Agents; D003510:Cyclohexanes; C064459:KDEL receptor; D046911:Macromolecular Substances; D008744:Methylamines; D018000:Receptors, Peptide; C118804:1,3-cyclohexanebis(methylamine); D020823:ADP-Ribosylation Factor 1; D009355:Neomycin